Eosinophilic Oesophagitis: Current Understanding and Future Directions

Christopher Ma, Eldon A. Shaffer
{"title":"Eosinophilic Oesophagitis: Current Understanding and Future Directions","authors":"Christopher Ma, Eldon A. Shaffer","doi":"10.33590/emjgastroenterol/10313659","DOIUrl":null,"url":null,"abstract":"Eosinophilic oesophagitis (EoE) is an emerging disorder that manifests clinically with characteristic symptoms of oesophageal dysfunction and histologically by tissue eosinophilia. This chronic immune-mediated oesophageal disease represents a response primarily to food antigens. The incidence of EoE is escalating in both adults and children. This rise stems not only from heightened recognition but also an increased frequency of allergic/atopic diseases and defective immune tolerance. In adults, EoE presents as intermittent solid-food dysphagia or food impaction, heartburn, and chest pain, typically presenting in young men with known allergies. Presentation differs in children, who experience upper gastrointestinal complaints: abdominal pain, vomiting, feeding difficulties, and/or failure to thrive. Endoscopic features include circular rings, linear furrows, white exudative plaques, strictures, and mucosal fragility. The pathologic hallmark of EoE is mucosal eosinophilia (>15 eosinophils per high-power field) isolated to the oesophagus. Such tissue eosinophilia must be distinguished from gastro-oesophageal acid reflux that responds to optimal proton pump inhibitor (PPI) treatment and from PPI-responsive oesophageal eosinophilia (PPI-ROE). Innovative modalities such as high resolution digitally-enhanced endoscopy and functional luminal impedance planimetry are emerging to better detect EoE and monitor its response to treatment. Current therapeutic strategies involve elimination and elemental diets to avoid food allergens, topical corticosteroids to counter the inflammatory response, and endoscopic dilation of fibrostenotic complications. Other treatments have employed immunosuppressants, antagonists to the leukotriene and T helper Type 2 inflammatory pathways, and biologics that target interleukins, tumour necrosis factor, or immunoglobulin E with variable success. This review highlights the current understanding of the epidemiology, pathogenesis, presentation, treatment, and natural history of EoE, and scrutinises current controversies and future directions for investigation.","PeriodicalId":92504,"journal":{"name":"EMJ. Gastroenterology","volume":"4 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2016-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EMJ. Gastroenterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33590/emjgastroenterol/10313659","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Eosinophilic oesophagitis (EoE) is an emerging disorder that manifests clinically with characteristic symptoms of oesophageal dysfunction and histologically by tissue eosinophilia. This chronic immune-mediated oesophageal disease represents a response primarily to food antigens. The incidence of EoE is escalating in both adults and children. This rise stems not only from heightened recognition but also an increased frequency of allergic/atopic diseases and defective immune tolerance. In adults, EoE presents as intermittent solid-food dysphagia or food impaction, heartburn, and chest pain, typically presenting in young men with known allergies. Presentation differs in children, who experience upper gastrointestinal complaints: abdominal pain, vomiting, feeding difficulties, and/or failure to thrive. Endoscopic features include circular rings, linear furrows, white exudative plaques, strictures, and mucosal fragility. The pathologic hallmark of EoE is mucosal eosinophilia (>15 eosinophils per high-power field) isolated to the oesophagus. Such tissue eosinophilia must be distinguished from gastro-oesophageal acid reflux that responds to optimal proton pump inhibitor (PPI) treatment and from PPI-responsive oesophageal eosinophilia (PPI-ROE). Innovative modalities such as high resolution digitally-enhanced endoscopy and functional luminal impedance planimetry are emerging to better detect EoE and monitor its response to treatment. Current therapeutic strategies involve elimination and elemental diets to avoid food allergens, topical corticosteroids to counter the inflammatory response, and endoscopic dilation of fibrostenotic complications. Other treatments have employed immunosuppressants, antagonists to the leukotriene and T helper Type 2 inflammatory pathways, and biologics that target interleukins, tumour necrosis factor, or immunoglobulin E with variable success. This review highlights the current understanding of the epidemiology, pathogenesis, presentation, treatment, and natural history of EoE, and scrutinises current controversies and future directions for investigation.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
嗜酸性粒细胞性食管炎:目前的认识和未来的方向
嗜酸性粒细胞性食管炎(EoE)是一种新出现的疾病,临床表现为食道功能障碍的特征性症状,组织学上表现为组织嗜酸性粒细胞增多。这种慢性免疫介导的食道疾病主要是对食物抗原的反应。在成人和儿童中,EoE的发病率都在上升。这种上升不仅源于认识的提高,而且还源于过敏/特应性疾病的频率增加和免疫耐受缺陷。在成人中,EoE表现为间歇性固体食物吞咽困难或食物嵌塞,胃灼热和胸痛,通常出现在已知过敏的年轻男性中。儿童的表现各不相同,他们会出现上消化道主诉:腹痛、呕吐、进食困难和/或发育不良。内窥镜特征包括圆环、线状沟、白色渗出斑块、狭窄和粘膜脆性。EoE的病理特征是孤立于食管的粘膜嗜酸性粒细胞增多(每高倍视场>15个嗜酸性粒细胞)。这种组织嗜酸性粒细胞增多必须与对最佳质子泵抑制剂(PPI)治疗有反应的胃-食管酸反流和对PPI有反应的食管嗜酸性粒细胞增多(PPI- roe)区分开来。诸如高分辨率数字增强内窥镜和功能性腔阻抗平面测量等创新方法正在出现,以更好地检测EoE并监测其对治疗的反应。目前的治疗策略包括消除和基本饮食以避免食物过敏原,局部使用皮质类固醇以对抗炎症反应,以及内窥镜扩张纤维狭窄并发症。其他治疗方法采用免疫抑制剂、白三烯拮抗剂和辅助性T 2型炎症途径,以及靶向白介素、肿瘤坏死因子或免疫球蛋白E的生物制剂,取得了不同程度的成功。本文综述了目前对脑炎的流行病学、发病机制、表现、治疗和自然史的认识,并详细分析了目前的争议和未来的研究方向。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
19 weeks
期刊最新文献
UEG 2023 Interview: Patrizia Burra Challenges in Management of Immune Checkpoint Inhibitor-Associated Hepatitis Preventive Medicine in Gastroenterology Severe, Refractory Anaemia Associated with Helicobacter Pylori Infection Managed With L. Reuteri DSMZ17648 (Probiotic) and Haeme Iron Supplements: A Case Report A Rare Complication of Valproate-Induced Acute Pancreatitis in an Adult Patient with Bipolar Disorder: A Case Report
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1